Huons - Ginome & Company signing a Microbiome joint research agreement
Huons - Ginome & Company signing a Microbiome joint research agreement
  • Lee Jun-sung
  • 승인 2019.01.28 13:35
  • 댓글 0
이 기사를 공유합니다

On January 25, a joint research agreement was held at the Pangyo headquarters in Hughes. Eum Ki-an, CEO of Huons (left) and Bae Ji-soo. CEO of Ginom & Company (right)

Huons is working on 'Probiotics and Microbiome' to secure next-generation growth engines in future bio areas.

Huons announced on January 28 that it signed a joint research and development agreement on diagnosis and treatment solutions using Microbiome platform technology with Genome & Company, which specializes in microbaiom, at its headquarters in Pangyo, Seongnam on January 25.

The main content is to develop diagnostic treatment solutions by combining Huons' various products such as professional medicine, health food products, and medical devices with the Microbiome database of Ginom & Company.

Huons and Ginom & Company establish a predictive model by correlating the patient's Microbiome data with the data obtained from clinical trials. 

In the future, Microbiome's analysis is expected to help predict the clinical state of patients, which will enable the establishment of new treatment systems and paradigms.

"We are going to actively push forward with developing innovative treatments and solutions in the future." said Eum Ki-an, CEO of Huons.

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: / Editorial Div. 02-578-0434 / 010-2442-9446. Email:
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.